Mersana Therapeutics所有资讯

Mersana Therapeutics | ARS：年度报告

04/26 18:28

Mersana Therapeutics | DEF 14A：股东委托书决议

04/26 18:09

Mersana Therapeutics | DEFA14A：其他

04/26 18:08

Mersana Therapeutics | 4：持股变动声明-董事 Alleva Lawrence M

04/04 08:19

Mersana Therapeutics | 8-K：重大事件

02/29 05:16

Mersana Therapeutics | 424B5：募资说明书

02/29 05:15

Mersana Therapeutics | POS AM：修改注册声明表

02/29 05:10

Mersana Therapeutics | 10-K：年度报表

02/28 21:52

Mersana Therapeutics | POSASR：注册声明修正稿

02/28 21:47

Mersana Therapeutics | 8-K：Mersana Therapeutics提供最新业务并公布2023年第四季度和全年财务业绩

02/28 20:12

Mersana Therapeutics | 4/A：持股变动声明(修正)-高管 Mandelia Ashish

02/17 05:33

Mersana Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(9.4%),VHCP Co-Investment Holdings III, LLC(9.4%)等

02/15 09:58

Mersana Therapeutics | SC 13G：超过5%持股股东披露文件-SilverArc Capital Management, LLC(5.3%),Devesh Gandhi(5.3%)

02/15 09:48

Mersana Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-OrbiMed Capital LLC(0.0%),OrbiMed Advisors LLC(0.0%)

02/15 07:58

Mersana Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Avoro Capital Advisors LLC(0%),Behzad Aghazadeh(0%)

02/14 22:22

Mersana Therapeutics | SC 13G：超过5%持股股东披露文件-Balyasny Asset Management L.P.(8.04%),BAM GP LLC(8.04%)等

02/14 20:26

Mersana Therapeutics | SC 13G：超过5%持股股东披露文件-The Vanguard Group(5.17%)

02/14 11:44

Mersana Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-BlackRock, Inc.(6.5%)

01/30 04:31

Mersana Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(1.93%)

01/22 13:00

Mersana Therapeutics | 4：持股变动声明-董事 Protopapas Anna

01/17 13:00